Axis Biotec Brasil is a holding company that sponsors and manages research, development and innovative business in the health and life sectors. With strong expertise in R&D, and also in sales and marketing, over the last 30 years, the companies of the group have been successful in translating research into innovative products and services in the health sector. Today, Axis Biotec is the major shareholder in four companies in Brazil: Silvestre Labs (pharmaceutical company), Cryopraxis (long-term biological material cryogenic bank), CellPraxis (bioengineering company focused in regenerative medicine and cell therapy) and PharmaPraxis (biopharmaceutical corporation). These companies, located in Rio de Janeiro’s Biotech Development Park, directly employ over 200 professionals and involve another 500 in various projects. If you are interested in finding out more about Axis Biotec’s projects, contact us: www.axisbiotec.com